ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. (2022)

First Author: Georgiou M

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41388-022-02251-8

PubMed Identifier: 35301407

Publication URI: http://europepmc.org/abstract/MED/35301407

Type: Journal Article/Review

Volume: 41

Parent Publication: Oncogene

Issue: 18

ISSN: 0950-9232